Choline Fenofibrate

Modify Date: 2025-08-24 18:15:32

Choline Fenofibrate structure	Common Name	Choline Fenofibrate
	CAS Number	856676-23-8	Molecular Weight	421.91400
	Density	N/A	Boiling Point	486.5ºC at 760 mmHg
	Molecular Formula	C₂₂H₂₈ClNO₅	Melting Point	N/A
	MSDS	N/A	Flash Point	248ºC

Use of Choline Fenofibrate

Choline Fenofibrate (ABT-335) is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia. IC50 value:Target:Several clinical trials have been developed with Choline Fenofibrate on Reverse Cholesterol Transport, Macular Edema and Hypertriglyceridemia.

Name	2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate,2-hydroxyethyl(trimethyl)azanium
Synonym	More Synonyms

Description	Choline Fenofibrate (ABT-335) is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia. IC50 value:Target:Several clinical trials have been developed with Choline Fenofibrate on Reverse Cholesterol Transport, Macular Edema and Hypertriglyceridemia.
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Cytochrome P450 Research Areas >> Cardiovascular Disease
References	[1]. Jones PH, Bays HE, Davidson MH et al. Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme. Clin Drug Investig. 2008;28(10):625-34. [2]. Mohiuddin SM, Pepine CJ, Kelly MT et al. Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study. Am Heart J. 2009 Jan;157(1):195-203. [3]. Zhu T, Awni WM, Hosmane B et al. ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans. J Clin Pharmacol. 2009 Jan;49(1):63-71. [4]. Goldberg AC, Bays HE, Ballantyne CM et al. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia. Am J Cardiol. 2009 Feb 15;103(4):515-22. [5]. Campbell J, Mohiuddin SM. The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. Drugs Today (Barc). 2010 Oct;46(10):757-64.

Description

Related Catalog

Signaling Pathways >> Metabolic Enzyme/Protease >> Cytochrome P450

Research Areas >> Cardiovascular Disease

References

[1]. Jones PH, Bays HE, Davidson MH et al. Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme. Clin Drug Investig. 2008;28(10):625-34.

[2]. Mohiuddin SM, Pepine CJ, Kelly MT et al. Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study. Am Heart J. 2009 Jan;157(1):195-203.

[3]. Zhu T, Awni WM, Hosmane B et al. ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans. J Clin Pharmacol. 2009 Jan;49(1):63-71.

[4]. Goldberg AC, Bays HE, Ballantyne CM et al. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia. Am J Cardiol. 2009 Feb 15;103(4):515-22.

[5]. Campbell J, Mohiuddin SM. The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. Drugs Today (Barc). 2010 Oct;46(10):757-64.

Boiling Point	486.5ºC at 760 mmHg
Molecular Formula	C₂₂H₂₈ClNO₅
Molecular Weight	421.91400
Flash Point	248ºC
Exact Mass	421.16600
PSA	86.66000
LogP	2.16320
Storage condition	2-8℃

Ethyl 2-bromois...

CAS#:600-00-0

4-p-Chlorobenzo...

CAS#:42019-78-3

Choline Hydroxide

CAS#:123-41-1

~70%

Choline Fenofibrate

CAS#:856676-23-8

Literature: US2008/275270 A1, ; Page/Page column 3 ;

Fenofibric acid

CAS#:42017-89-0

Choline chloride

CAS#:67-48-1

~75%

Choline Fenofibrate

CAS#:856676-23-8

Literature: WO2010/86700 A2, ; Page/Page column 7 ;

Isopropyl 2-bro...

CAS#:51368-55-9

4-p-Chlorobenzo...

CAS#:42019-78-3

Choline Hydroxide

CAS#:123-41-1

~68%

Choline Fenofibrate

CAS#:856676-23-8

Literature: US2008/275270 A1, ; Page/Page column 3 ;

Precursor 6
CAS#:600-00-0 Ethyl 2-bromois... CAS#:42019-78-3 4-p-Chlorobenzo... CAS#:123-41-1 Choline Hydroxide CAS#:42017-89-0 Fenofibric acid
CAS#:67-48-1 Choline chloride CAS#:51368-55-9 Isopropyl 2-bro...
DownStream 0

Choline fenofibrate

UNII-4BMH7IZT98

fenofibric acid choline salt

ABT-335

Fenofibrate de choline

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Choline Fenofibrate

Use of Choline Fenofibrate

Names

Choline Fenofibrate Biological Activity

Chemical & Physical Properties

Synthetic Route

Precursor & DownStream

Synonyms

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.